CancerX shared on LinkedIn:
“‘If you’re building in cancer and want to do it thoughtfully, strategically, and alongside the right people, I’d definitely encourage you to apply. CancerX is one of the few places where conversations are truly visionary.’ – Shelby Yaceczko, Founder and CEO, F-U Cancer | CancerX Cohort 2026.
Building a startup in oncology is hard.
The science is complex, the stakes are deeply human, and no founder should have to navigate it alone.
That’s where CancerX comes in.
Why apply to Cohort 2027?
- The right people: clinicians, patients, payers & industry leaders in your corner
- Strategic guidance: grow with purpose, not just react
- Patient-centered thinking: innovation that truly improves lives
If you’re a founder on a mission to change the future of cancer care, we’d love to meet you.
Applications are open; apply today and join the next CancerX cohort!
Start your application here by creating or signing into your Constellation account: Join Constellation.”
Other articles about CancerX on OncoDaily.